search
Back to results

Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects

Primary Purpose

Periodontal Diseases

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
DFDBA
Regenafil
Sponsored by
RTI Surgical
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Periodontal Diseases focused on measuring Periodontal Treatment of Intraosseous Vertical Defects

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Provide written informed consent prior to their participation. Be an adult age 18 and older. Have at least a 4 mm open vertical osseous defect depth on one tooth, visible on a radiograph and with a probing depth ≥ 5 mm. Have osseous defects that are either wide 3-wall, or combination defects. Exclusion Criteria: Have debilitating systemic diseases, or diseases that affect the periodontium. Have a known allergy to any of the materials that will be used in the study: non-steroidal anti-inflammatory drugs (NSAIDs) chlorhexidine digluconate doxycycline gelatin Need prophylactic antibiotics. Have a vertical osseous defect that is related to a furcation area. Smoke more than 1 pack per day. Have endodontically treated teeth or endodontic lesions at study sites. Have 1-wall defects. Have poor oral hygiene. Have anterior fillings (Note: if a subject presents with anterior fillings, it will be at the discretion of the principal investigator as to whether they should be accepted into the study.) Be pregnant as evidenced by a positive urine pregnancy test taken at both the screening and baseline visits.

Sites / Locations

  • Indiana University School of Dentistry
  • University of Louisville School of Dentistry

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Regenafil graft

DFDBA

Arm Description

Regenafil

Demineralized Freeze Dried Bone Allograft

Outcomes

Primary Outcome Measures

Change in Probing Depth
This is the distance, measured in millimeters (mm) from the gingival margin to the maximal penetration of the probe tip. The measures were made at baseline and then at 6 months after treatment.
Clinical Attachment Level
The amount of space between attached periodontal tissues and a fixed point, usually the cementoenamel junction. A measurement used to assess the stability of attachment as part of a periodontal maintenance program.
Recession
CEJ to gingival margin (GM). GM coronal to the CEJ were scored as a negative number.

Secondary Outcome Measures

Gingival Index
Scores: 0 Normal gingiva Mild inflammation Moderate inflammation Severe inflammation Gingival units (buccal, lingual, mesiobuccal, distobuccal, mesiolingual, and distolingual) of each tooth were scored 0-3. Scores from the 6 areas of the tooth were added and divided by 6 to give the gingival index for the entire tooth.
Plaque Index
0- No plaque A film of plaque adhering to gingival margin & adjacent area of tooth Moderate accumulation of soft deposits, visible with the naked eye Abundance of soft matter Each gingival region of the individual tooth will be scored 0-3 The scores from the 6 areas of the tooth are averaged to give the plaque index for the tooth.
Bleeding on Probing
The variable measured the presence of bleeding when the osseus defect was probed. The presence and character of gingival bleeding will be determined by gently probing to the base of the pockets. 0 - No bleeding. 1 - Bleeding when probing.
Mobility Index
Tooth mobility was recorded using Miller's Index: - up to 1 mm of movement in a horizontal direction - greater than 1 mm of movement in a horizontal direction - excessive horizontal movement and vertical movement. Manual evaluation of mobility was carried out clinically using the handles of two instruments to move the teeth buccally and lingually and note their movement.

Full Information

First Posted
November 16, 2005
Last Updated
August 8, 2011
Sponsor
RTI Surgical
search

1. Study Identification

Unique Protocol Identification Number
NCT00255970
Brief Title
Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects
Official Title
Regenerative Therapy for Vertical Defects Comparing Demineralized Freeze Dried Bone Allograft (DFDBA) and Regenafil
Study Type
Interventional

2. Study Status

Record Verification Date
August 2011
Overall Recruitment Status
Completed
Study Start Date
January 2006 (undefined)
Primary Completion Date
November 2007 (Actual)
Study Completion Date
November 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
RTI Surgical

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this research study was to determine whether treatment with the bone grafting material Regenafil was as effective as the standard treatment using demineralized freeze dried bone allograft (DFDBA). Regenafil is demineralized freeze dried bone in a special gel form.
Detailed Description
To compare the regenerative effects of a demineralized freeze dried bone allograft (DFDBA) particulate in a biologic thermoplastic carrier (Regenafil) to the standard of care. To compare the regenerative effects of a demineralized freeze dried bone allograft (DFDBA) particulate in the treatment of intraosseous vertical defects following six months of healing. This was accomplished by evaluating clinical parameters including probing depth, attachment level and bleeding upon probing, using attachment level as the primary outcome variable. Treatment of the vertical osseous defect is a challenging problem in periodontics. There are many treatment options including: open flap debridement; osseous graft alone; membrane alone; or membrane plus an osseous graft. Choice of treatment may depend on the defect depth and configuration. A shallow, narrow 3 wall defect may respond well to open flap debridement while a deep 2 wall defect may need regenerative therapy such as an osseous graft, a membrane or combined membrane and graft treatment. Studies of vertical defect therapy with defects about 4 mm or greater show that similar percent defect fill results are obtained with regenerative therapies. Open flap debridement produces substantially less percent defect fill.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Periodontal Diseases
Keywords
Periodontal Treatment of Intraosseous Vertical Defects

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Regenafil graft
Arm Type
Experimental
Arm Description
Regenafil
Arm Title
DFDBA
Arm Type
Active Comparator
Arm Description
Demineralized Freeze Dried Bone Allograft
Intervention Type
Other
Intervention Name(s)
DFDBA
Other Intervention Name(s)
Demineralized Bone Matrix
Intervention Description
Demineralized Freeze Dried Allograft bone
Intervention Type
Device
Intervention Name(s)
Regenafil
Other Intervention Name(s)
Demineralized Freeze Dried Bone Allograft
Intervention Description
Demineralized Freeze Dried Bone in a porcine gel carrier
Primary Outcome Measure Information:
Title
Change in Probing Depth
Description
This is the distance, measured in millimeters (mm) from the gingival margin to the maximal penetration of the probe tip. The measures were made at baseline and then at 6 months after treatment.
Time Frame
baseline and then at 6 months
Title
Clinical Attachment Level
Description
The amount of space between attached periodontal tissues and a fixed point, usually the cementoenamel junction. A measurement used to assess the stability of attachment as part of a periodontal maintenance program.
Time Frame
6 months
Title
Recession
Description
CEJ to gingival margin (GM). GM coronal to the CEJ were scored as a negative number.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Gingival Index
Description
Scores: 0 Normal gingiva Mild inflammation Moderate inflammation Severe inflammation Gingival units (buccal, lingual, mesiobuccal, distobuccal, mesiolingual, and distolingual) of each tooth were scored 0-3. Scores from the 6 areas of the tooth were added and divided by 6 to give the gingival index for the entire tooth.
Time Frame
6 months
Title
Plaque Index
Description
0- No plaque A film of plaque adhering to gingival margin & adjacent area of tooth Moderate accumulation of soft deposits, visible with the naked eye Abundance of soft matter Each gingival region of the individual tooth will be scored 0-3 The scores from the 6 areas of the tooth are averaged to give the plaque index for the tooth.
Time Frame
6 months
Title
Bleeding on Probing
Description
The variable measured the presence of bleeding when the osseus defect was probed. The presence and character of gingival bleeding will be determined by gently probing to the base of the pockets. 0 - No bleeding. 1 - Bleeding when probing.
Time Frame
6 months
Title
Mobility Index
Description
Tooth mobility was recorded using Miller's Index: - up to 1 mm of movement in a horizontal direction - greater than 1 mm of movement in a horizontal direction - excessive horizontal movement and vertical movement. Manual evaluation of mobility was carried out clinically using the handles of two instruments to move the teeth buccally and lingually and note their movement.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Provide written informed consent prior to their participation. Be an adult age 18 and older. Have at least a 4 mm open vertical osseous defect depth on one tooth, visible on a radiograph and with a probing depth ≥ 5 mm. Have osseous defects that are either wide 3-wall, or combination defects. Exclusion Criteria: Have debilitating systemic diseases, or diseases that affect the periodontium. Have a known allergy to any of the materials that will be used in the study: non-steroidal anti-inflammatory drugs (NSAIDs) chlorhexidine digluconate doxycycline gelatin Need prophylactic antibiotics. Have a vertical osseous defect that is related to a furcation area. Smoke more than 1 pack per day. Have endodontically treated teeth or endodontic lesions at study sites. Have 1-wall defects. Have poor oral hygiene. Have anterior fillings (Note: if a subject presents with anterior fillings, it will be at the discretion of the principal investigator as to whether they should be accepted into the study.) Be pregnant as evidenced by a positive urine pregnancy test taken at both the screening and baseline visits.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Henry Greenwell, DMD
Organizational Affiliation
University of Louisville
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Steven Blanchard, DDS
Organizational Affiliation
Indiana University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Indiana University School of Dentistry
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202
Country
United States
Facility Name
University of Louisville School of Dentistry
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects

We'll reach out to this number within 24 hrs